Dr. Siew Wai FONG is Programme Lead at the A*STAR Infectious Diseases Labs. She earned her Ph.D. in Human Physiology from Universiti Sains Malaysia and completed postdoctoral training at the National University of Singapore. Her research focuses on mosquito-borne viruses such as dengue and chikungunya, with a distinctive emphasis on mosquito salivary immunomodulators. She specialises in translational immunology, developing immune assays and host-based diagnostics to support clinical decision-making. During the COVID-19 pandemic, she contributed to national immunophenotyping efforts, identifying biomarkers that informed therapeutic strategies and vaccine development. Her work has been published in The Lancet, Nature Communications, and EMBO, and she was awarded Singapore’s COVID-19 Resilience Medal in recognition of her contributions. Ultimately, her research aims to advance therapeutics and diagnostics that strengthen global health security and enhance epidemic preparedness.